Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. The consensus fair value ...

Shares of Theravance Biopharma TBPH plunged 26% after the company announced the failure of the late-stage CYPRESS study ...

Academic program reviews (not associated with accreditation reviews) are to occur every 8 years according to a published timetable included in this document. Important characteristics of the academic ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced topline results from the Phase 3 CYPRESS study evaluating the efficacy and safety of ampreloxetine ...

Learn about unique Medicare insurance benefits that can help retirees save on health care costs and make the most of their ...

Wow! One hundred percent across the board! That is what Rodgers Forge Elementary School Principal Missy Fanshaw saw when she pulled up the results of the Maryland State Assessment Test.

Phase 3 CYPRESS study did not meet the primary endpoint, the OHSA Composite Score, a patient reported outcome (PRO) Cash of $326.5 million at Q4 2025 (no debt); ...

Theravance Biopharma said it is chopping its workforce by 50% and launching a review of strategic alternatives designed to maximize shareholder value, after its sole rare disease pipeline candidate, ...

Staff Monitored Programs (SMPs) are informal agreements between national authorities and IMF staff to monitor the authorities’ economic program. As such, they do not entail endorsement by the IMF ...

At this time, I'd like to welcome everyone to the CubeSmart Fourth Quarter 2025 Earnings Call. [Operator Instructions] I'd now like to turn the call over to Josh Schutzer, Senior Vice President of ...

State regulators release revised enforcement instructions to guide employers through evolving compliance requirements and inspection protocols.

Our new patent-pending BMS has been released on our first two models Z-Viper and Z-Python. Please visit our website for ...